anvajo GmbH acquires 9.5 Million Euros

anvajo successfully raised 9.5 million euros in September. A strategic new investor brought in 7.5 million euros, while existing investors continued their support with 2.0 million euros. This confirms the confidence in anvajo’s innovative strength and future-oriented business model. The money raised will enable anvajo to further develop its technology and drive growth.

anvajo’s mission is to provide access to laboratory diagnostics for everyone, everywhere. The company develops and markets point-of-care devices that analyze liquids quickly, cost-effectively and reliably. At the core of the technology are digital holographic microscopy and a compact spectrometer. Together, they form the basis of the fluidlab platform. The first-generation fluidlab device is used in point-of-care diagnostics, research, and industry. It provides a portable, cost-effective lab solution for precise analyses. The fluidlab is attracting growing interest across healthcare and life science sectors. In early 2024, the second-generation fluidlab launched with a partner company.

“Our vision is better healthcare in which diseases can be detected more quickly, therapies can be developed more efficiently and their progress can be tracked more accurately”, explains Stefan Fraedrich, Founder and Managing Director of anvajo. “With the new financing, we will be able to intensify the further development of our products and open up new markets for our fluidlab platform.”